Plans from major carriers like Medicaid, Aetna, Blue Cross Blue Shield, UnitedHealthcare, and Cigna often provide benefits for FDA-approved weight loss medications, but verification and prior authorizations are necessary steps in the process
Other large-scale studies using different datasets have also found beneficial effects with GLP-1RAs on other outcomes, including the frequency and quantity of alcohol use as measured by alcohol use disorders identification test-consumption (AUDIT-C) [231], alcohol-related events [232], intoxication [233], and hospitalizations [234]
The most notable increase in risk was found for a type of stomach cancer known as gastric carcinoid tumors
When the time comes for Metsera to run large Phase 3 trials, Meanwell says, its likely those will be the primary outcomes, with weight loss as a secondary end point